Compare WVE & VTOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | VTOL |
|---|---|---|
| Founded | 2012 | 1948 |
| Country | Singapore | United States |
| Employees | N/A | 3660 |
| Industry | Biotechnology: Pharmaceutical Preparations | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2015 | 2011 |
| Metric | WVE | VTOL |
|---|---|---|
| Price | $6.06 | $43.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 3 |
| Target Price | $29.81 | ★ $58.00 |
| AVG Volume (30 Days) | ★ 3.1M | 276.8K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | N/A | ★ 34.58 |
| EPS | N/A | ★ 0.44 |
| Revenue | $3,704,000.00 | ★ $1,490,512,000.00 |
| Revenue This Year | N/A | $11.64 |
| Revenue Next Year | $85.67 | $5.59 |
| P/E Ratio | ★ N/A | $98.05 |
| Revenue Growth | ★ 149.43 | 5.30 |
| 52 Week Low | $5.02 | $32.76 |
| 52 Week High | $21.73 | $50.38 |
| Indicator | WVE | VTOL |
|---|---|---|
| Relative Strength Index (RSI) | 48.57 | 56.36 |
| Support Level | $6.02 | $42.83 |
| Resistance Level | $6.31 | $44.42 |
| Average True Range (ATR) | 0.32 | 1.07 |
| MACD | 0.07 | 0.29 |
| Stochastic Oscillator | 57.95 | 81.00 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Bristow Group Inc is the provider of vertical flight solutions. The group provides aviation services to a broad base of offshore energy companies and government entities. Its business comprises three reportable segments: Offshore Energy Services, Government Services, and Other Services. Its customers are in the UK, Norway, the USA, Nigeria, and Others. The offshore energy customers use services to transport personnel to, from and between offshore energy installations. The majority of revenue is generated from Offshore Energy Services.